Health Tech

Open Source

Austin-based Luminex completes $77 million deal to buy Nanosphere

UPDATED on June 30: It's official: Luminex Corp. bought Nanosphere for $77 million.  The Austin medical diagnostics company said Thursday it has completed its purchase of Nanosphere. Illinois-based Nanospehre makes  diagnostic tools that allow for...

Read More

Austin startups join the A-List

The Greater Austin Chamber of Commerce has unveiled its annual A-List, which spotlights a dozen local startup companies that the chamber says have breakout potential. This year, nearly 200 companies were nominated, and the winners were announced Thursday...

Read More

Open Source

How does pet cloning work, exactly?

We recently documented how the owner of a local animal cloning company is being attacked by short-sellers.  Located in Cedar Park, a suburb of Austin, ViaGen clones animals mainly for breeders, such as cattle or horses. But last year they decided...

Read More

What a short-seller's attack means for Central Texas animal cloning company ViaGen

Three weeks ago I was set to interview the president of Austin-based pet cloning company ViaGen, which is based in Cedar Park, when I got an email abruptly canceling the interview.  The PR contact told me that ViaGen's parent company, Intrexon, had...

Read More

Austin-based Luminex sees revenue, profit rise in 1st quarter

LUMINEX WHAT THEY DO: Luminex develops biological testing systems. Their testing systems allow a tiny sample of blood to be tested for dozens of biological markers. It can be used for gene-based research and diagnostics.  The company was founded in...

Read More

Austin health diagnostics startup EverlyWell raises $2.5 million 

After moving its headquarters from Dallas to Austin in March, startup EverlyWell has raised $2.5 million  to launch its at-home health care diagnostics business. Founded in 2015, EverlyWell currently offers testing for food sensitivity, women's health...

Read More

Two Austin biotech companies reached fundraising milestones

In the inaugural edition of "512talk," our weekly video chat of the week's tech news, reporters Lori Hawkins and Lilly Rockwell discuss the two Austin biotech companies that dominated the news this week. 

Read More

Austin's Aeglea BioTherapeutics makes $50 million on IPO

Austin officially has another publicly traded company.  Aeglea BioTherapeutics Inc. on Thursday raised $50 million in an initial public offering, with an initial share price of $10. In its first day of trading on the Nasdaq exchange the stock closed...

Read More

Austin's Lumos Pharma raises $34 million to fight rare genetic disease

An Austin biotech company that's developing a new therapy for a rare genetic disease has raised $34 million to launch clinical tests. Lumos Pharma, founded in 2011, will use the money to test and commercialize a therapeutic treatment for those suffering...

Read More